Fonte: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP
Assuntos: HIPERTENSÃO, DOENÇAS VASCULARES
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 23 ago. 2024.APA
Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096NLM
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096Vancouver
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096